Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/1999
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883085 Salicylic acid for treatment of skins
03/16/1999US5883078 Hemostyptic and tissue adhesive
03/16/1999US5882647 Aquatic animal treatment method and composition containing cajeput oil
03/16/1999CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
03/16/1999CA1340445C Diamino-2,4-pyrimidine 3-oxide derivatives and their use for the prevention and treatment of hair loss
03/11/1999WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999WO1999011666A1 N-terminal modifications of rantes and methods of use
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011293A1 50 human secreted proteins
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1999011249A2 Use of endipalene in the treatment of psoriasis
03/11/1999WO1999011239A1 Method for preparing pharmaceutical formulations
03/11/1999WO1999011238A1 Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins
03/11/1999WO1999011237A1 Dermatological compositions
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999WO1998049300A3 Truncated vegf-related proteins
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2302241A1 A new chemical entity (endipalene) in the treatment of psoriasis
03/11/1999CA2301325A1 Method for preparing pharmaceutical formulations
03/11/1999CA2300046A1 N-terminal modifications of rantes and methods of use
03/11/1999CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900561A1 Compositions promoting collagen production
03/10/1999EP0900559A1 Use of a dispersion based on lipid vesicles as an anti-inflammatory composition
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900211A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
03/10/1999EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis
03/10/1999EP0900198A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999CN1210540A Triazole derivatives useful in therapy
03/10/1999CN1042394C Pharmaceutical composition containing felbinac
03/09/1999US5880152 Inflammatory bowel disease
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880124 For treatment of hypotension
03/09/1999US5880113 Antiproliferative agents, cell differentiation inducers
03/09/1999US5879711 Stable antiandrogenic gel composition
03/09/1999US5879692 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
03/09/1999US5879690 Increasing muscle tone in subcutaneous muscle tissue
03/09/1999US5879688 Treatment of skin disorders, wrinkling, aging
03/09/1999US5879665 Extract of johimbe tree bark and topical vehicle or carrier
03/04/1999WO1999010363A1 29 human secreted proteins
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010322A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999010308A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999010007A1 Methods and compositions for enhanced wound healing
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999WO1999009982A1 Prevention of adhesions and excessive scar formation using angiogenesis inhibitors
03/04/1999WO1999009969A1 Treatment of cell-mediated immune diseases
03/04/1999WO1999009945A1 Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology
03/04/1999WO1998055074A3 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
03/04/1999CA2302387A1 29 human secreted proteins
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242258A1 Novel compounds
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0899339A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899330A1 Polypeptide isolated from the epidermis and its use
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
03/03/1999EP0898579A1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
03/03/1999EP0898559A2 Cytoprotective compounds
03/03/1999EP0627909B1 Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract
03/03/1999CN1209739A Medicament forms constituted in situ for releasing enzymes into wounds
03/03/1999CN1209738A Skin-care composition
03/03/1999CN1209335A Plaster for treating wound
03/03/1999CN1209318A Nailpolish having function of resisting psoriasis
03/03/1999CN1209317A Medicine for treating wound
03/03/1999CA2242313A1 Signal recognition particle polypeptides and polynucleotides
03/02/1999US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders
03/02/1999US5877212 Molecular complex and control-release of alpha hydroxyacids
03/02/1999US5877207 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/02/1999US5877176 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
03/02/1999US5876737 Use of salicin as an anti-irritative active compound in cosmetic and topical dermatological preparations
03/02/1999US5876730 Heparin-binding growth factor (HBGF) polypeptides
03/02/1999CA2242315A1 Mecb
03/01/1999CA2242311A1 Novel compounds
02/1999
02/28/1999CA2241427A1 Novel pyrr homolog
02/26/1999CA2241431A1 Novel spoiiie
02/25/1999WO1999009152A1 Human frezzled-like protein
02/25/1999WO1999009146A1 Human serum inducible kinase (snk)
02/25/1999WO1999009061A1 Secreted proteins
02/25/1999WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999WO1999009030A1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
02/25/1999WO1999009011A1 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
02/25/1999WO1999008994A1 Anti-cancer compounds
02/25/1999WO1999008707A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient
02/25/1999WO1999008673A1 Enantiomers of 4-[[(cyanoimino)- [(1,2,2-trimethylpropyl) amino]methyl]amino] benzonitrile
02/25/1999WO1999008654A1 USE OF 17-α-ESTRADIOL FOR THE TREATMENT OF AGED OR SUNDAMAGED SKIN AND/OR SKIN ATROPHY
1 ... 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 ... 1065